Xenetic BiosciencesXBIO
13F holders, Q1 2026 (March 31)6holders −5
0new positions
6sold out
1famous investor
$2.68avg. 13F price*
At the end of Q1 2026, 6 institutions reported holding Xenetic Biosciences Inc. (XBIO) in their 13F filings, down 5 from Q4 2025. 0 opened new positions and 6 sold out. The largest holders were Renaissance Technologies ($368K), Geode Capital Management, LLC ($57K) and Vanguard Capital Management LLC ($18K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Xenetic Biosciences Inc.
- CUSIP
- 984015602
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 6 | $65K |
All 13F filers, Q4 2025 → Q1 2026: 7,860 shares bought and 74,265 shares sold, net −66,405 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Renaissance Technologies | 0.00% | Reduce -23.0% | 137,440 | $368K |
| Geode Capital Management, LLC | 0.00% | Add +57.9% | 21,441 | $57K |
| Vanguard Capital Management LLC | 0.00% | — | 6,731 | $18K |
| JTC Employer Solutions Trustee Ltd | 0.00% | No change | 2,700 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -79.9% | 806 | $2K |
| Darwin Wealth Management, LLC | 0.00% | No change | 2 | $5 |
"% of holder's portfolio" is XBIO's weight in each manager's 13F, not the share of Xenetic Biosciences Inc. the manager owns.